Edith Hanna

Edith Hanna

Auto-generated profile, based on publicly available information

Edith Hanna

Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2016 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
EHEdith Hanna
Edith Hanna
RARami Abadi
Rami Abadi
OAOssama Abbas
Ossama Abbas

1 November 2014 in Cell Reports
Verified
Journal Article
Open access
DCDenise Cook
Denise Cook
ENErin Nuro
Erin Nuro
EJEmma V. Jones
Emma V. Jones
HAHaider F. Altimimi
Haider F. Altimimi
WFW. Todd Farmer
W. Todd Farmer
KMKeith K. Murai
Keith K. Murai
Translational control of mRNAs allows for rapid and selective changes in synaptic protein expression that are required for long-lasting plasticity and memory formation in the brain. Fragile X Related Protein 1 (FXR1P) is an RNA-binding protein that controls mRNA translation in nonneuronal cells and colocalizes with translational machinery in neurons. However, its neuronal mRNA targets and role in the brain are unknown. Here, we demonstrate that removal of FXR1P from the forebrain of postnatal mice selectively enhances long-term storage of spatial memories, hippocampal late-phase long-term potentiation (L-LTP), and de novo GluA2 synthesis. Furthermore, FXR1P binds specifically to the 5' UTR of GluA2 mRNA to repress translation and limit the amount of GluA2 that is incorporated at potentiated synapses. This study uncovers a mechanism for regulating long-lasting synaptic plasticity and spatial memory formation and reveals an unexpected divergent role of FXR1P among Fragile X proteins in brain plasticity.

14 September 2021 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
EHEdith Hanna
Edith Hanna
LXLin Xing
Lin Xing
JTJennifer H. Taylor
Jennifer H. Taylor
VBVince Bertucci
Vince Bertucci

28 November 2019 in American Journal of Clinical Dermatology
Verified
Journal Article
Closed access
PDF file
EHEdith Hanna
Edith Hanna
KPKucy Pon
Kucy Pon

13 June 2016 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
MDMohammed Dany
Mohammed Dany
RNRose Nganga
Rose Nganga
ACAlissar Chidiac
Alissar Chidiac
EHEdith Hanna
Edith Hanna
SMSara Matar
Sara Matar
DEDirk Elston
Dirk Elston
Melanoma remains a leading cause of death among young adults. Evidence that melanoma tumor cells are highly immunogenic and a better understanding of T-cell immune checkpoints have changed the therapeutic approach to advanced melanoma. Instead of targeting the tumor directly, immunotherapy targets and activates the immune response using checkpoint inhibitors, monoclonal antibodies, vaccines, and adoptive T cell therapy. This review focuses on the immune signaling and biological mechanisms of action of recent immune-based melanoma therapies as well as their clinical benefits.

31 May 2013 in Public Health
Verified
Journal Article
Closed access
PDF file
GAG. Alaaeddine
G. Alaaeddine
TKT. Al Kuhaimi
T. Al Kuhaimi
RAR. Al Assaad
R. Al Assaad
MDM. Dany
M. Dany
RDR. Diab
R. Diab
RNRima Nakkash
Rima Nakkash